Related Experiment Video
Updated: Jul 15, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study
Miguel A Gonzalez-Gay1, Jose A Miranda-Filloy, Maria J Lopez-Diaz
1From Divisions of Rheumatology (MAG-G, JAM-F, MJL-D, AS-A) and Cardiology (CG-J), Hospital Xeral-Calde, Lugo; Division of Medicine (RP-A), Hospital Meixoeiro, Vigo; Instituto de Parasitologia y Biomedicina Lopez-Neyra (JM), CSIC, Granada; and Division of Preventive Medicine and Public Health (JL), School of Medicine, University of Cantabria, Santander, Spain.
Giant cell arteritis (GCA) incidence increased progressively in northwestern Spain from 1981-2005. Researchers observed a decline in visual complications, suggesting a changing clinical spectrum for this vasculitis.
Area of Science:
- Epidemiology
- Rheumatology
- Ophthalmology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large and medium-sized arteries, primarily in individuals over 50.
- Understanding GCA epidemiology is crucial for public health planning and resource allocation.
- Previous studies have indicated geographic variations in GCA incidence and clinical presentation.
Purpose of the Study:
- To investigate trends in the incidence of biopsy-proven GCA over a 25-year period (1981-2005) in Lugo, Spain.
- To identify any changes in the clinical spectrum of GCA, specifically focusing on visual manifestations.
- To analyze potential peaks, fluctuations, or seasonal patterns in GCA diagnosis.
Main Methods:
- Retrospective analysis of biopsy-proven GCA cases diagnosed in Lugo residents between 1981 and 2005.
- Calculation of age- and sex-adjusted annual incidence rates per 100,000 population (aged 50+).
- Statistical analysis to assess trends in incidence and clinical manifestations, including visual complications.
Main Results:
- A total of 255 biopsy-proven GCA cases were identified.
- The age- and sex-adjusted annual incidence rate was 10.13 per 100,000 population (50+).
- A progressive increase in GCA incidence was observed from 1981 through 2000 (p=0.001).
- No significant peaks or seasonal patterns in incidence were detected.
- Visual ischemic manifestations and irreversible visual loss occurred in 22.4% and 12.5% of patients, respectively.
- A significant negative trend was observed, with a decline in visual ischemic manifestations (p=0.021) and permanent visual loss (p=0.018) over the study period.
Conclusions:
- The incidence of biopsy-proven GCA has progressively increased in northwestern Spain.
- There has been a significant decline in the frequency of visual manifestations associated with GCA.
- These findings suggest a potential change in the clinical spectrum of GCA over the past 25 years.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies
Hypertension III: Clinical Manifestations and Diagnostic Studies
